494 related articles for article (PubMed ID: 33193439)
1. Visualization of Diagnostic and Therapeutic Targets in Glioma With Molecular Imaging.
Li D; Patel CB; Xu G; Iagaru A; Zhu Z; Zhang L; Cheng Z
Front Immunol; 2020; 11():592389. PubMed ID: 33193439
[TBL] [Abstract][Full Text] [Related]
2. Hybrid 11C-MET PET/MRI Combined With "Machine Learning" in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016.
Kebir S; Weber M; Lazaridis L; Deuschl C; Schmidt T; Mönninghoff C; Keyvani K; Umutlu L; Pierscianek D; Forsting M; Sure U; Stuschke M; Kleinschnitz C; Scheffler B; Colletti PM; Rubello D; Rischpler C; Glas M
Clin Nucl Med; 2019 Mar; 44(3):214-220. PubMed ID: 30516675
[TBL] [Abstract][Full Text] [Related]
3. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.
Jiang S; Zou T; Eberhart CG; Villalobos MAV; Heo HY; Zhang Y; Wang Y; Wang X; Yu H; Du Y; van Zijl PCM; Wen Z; Zhou J
Magn Reson Med; 2017 Sep; 78(3):1100-1109. PubMed ID: 28714279
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
[TBL] [Abstract][Full Text] [Related]
5. Imaging of Intracranial Gliomas.
Ono Y; Chernov MF; Muragaki Y; Maruyama T; Abe K; Iseki H
Prog Neurol Surg; 2018; 30():12-62. PubMed ID: 29241169
[TBL] [Abstract][Full Text] [Related]
6. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.
Kong Z; Yan C; Zhu R; Wang J; Wang Y; Wang Y; Wang R; Feng F; Ma W
Neuroimage Clin; 2018; 20():51-60. PubMed ID: 30069427
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas.
Röhrich M; Huang K; Schrimpf D; Albert NL; Hielscher T; von Deimling A; Schüller U; Dimitrakopoulou-Strauss A; Haberkorn U
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1573-1584. PubMed ID: 29732524
[TBL] [Abstract][Full Text] [Related]
8. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
9. Accurate Delineation of Glioma Infiltration by Advanced PET/MR Neuro-Imaging (FRONTIER Study): A Diagnostic Study Protocol.
Verburg N; Pouwels PJ; Boellaard R; Barkhof F; Hoekstra OS; Reijneveld JC; Vandertop WP; Wesseling P; de Witt Hamer PC
Neurosurgery; 2016 Oct; 79(4):535-40. PubMed ID: 27479710
[TBL] [Abstract][Full Text] [Related]
10. ⁹⁰Y-based PET and SPECT/CT imaging in locoregional brain treatment for high-grade gliomas: retrospective fusion with MRI.
Fabbri C; Mattone V; Sarti G; Casi M; De Lauro F; Agostini M; Bartolini N; Bartolomei M
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1822-3. PubMed ID: 22872309
[No Abstract] [Full Text] [Related]
11. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.
Albert NL; Weller M; Suchorska B; Galldiks N; Soffietti R; Kim MM; la Fougère C; Pope W; Law I; Arbizu J; Chamberlain MC; Vogelbaum M; Ellingson BM; Tonn JC
Neuro Oncol; 2016 Sep; 18(9):1199-208. PubMed ID: 27106405
[TBL] [Abstract][Full Text] [Related]
12. Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.
Verburg N; Koopman T; Yaqub MM; Hoekstra OS; Lammertsma AA; Barkhof F; Pouwels PJW; Reijneveld JC; Heimans JJ; Rozemuller AJM; Bruynzeel AME; Lagerwaard F; Vandertop WP; Boellaard R; Wesseling P; de Witt Hamer PC
Neuro Oncol; 2020 Mar; 22(3):412-422. PubMed ID: 31550353
[TBL] [Abstract][Full Text] [Related]
13. PET, MRI, and simultaneous PET/MRI in the development of diagnostic and therapeutic strategies for glioma.
Puttick S; Bell C; Dowson N; Rose S; Fay M
Drug Discov Today; 2015 Mar; 20(3):306-17. PubMed ID: 25448762
[TBL] [Abstract][Full Text] [Related]
14. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
Rieken S; Habermehl D; Giesel FL; Hoffmann C; Burger U; Rief H; Welzel T; Haberkorn U; Debus J; Combs SE
Radiother Oncol; 2013 Dec; 109(3):487-92. PubMed ID: 23953407
[TBL] [Abstract][Full Text] [Related]
15. Relevance of calcification and contrast enhancement pattern for molecular diagnosis and survival prediction of gliomas based on the 2016 World Health Organization Classification.
Michiwaki Y; Hata N; Mizoguchi M; Hiwatashi A; Kuga D; Hatae R; Akagi Y; Amemiya T; Fujioka Y; Togao O; Suzuki SO; Yoshimoto K; Iwaki T; Iihara K
Clin Neurol Neurosurg; 2019 Dec; 187():105556. PubMed ID: 31639630
[TBL] [Abstract][Full Text] [Related]
16. Advances in Magnetic Resonance Imaging and Positron Emission Tomography Imaging for Grading and Molecular Characterization of Glioma.
Chung C; Metser U; Ménard C
Semin Radiat Oncol; 2015 Jul; 25(3):164-71. PubMed ID: 26050586
[TBL] [Abstract][Full Text] [Related]
17. Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus.
Schiff D; Van den Bent M; Vogelbaum MA; Wick W; Miller CR; Taphoorn M; Pope W; Brown PD; Platten M; Jalali R; Armstrong T; Wen PY
Neuro Oncol; 2019 Jul; 21(7):837-853. PubMed ID: 30753579
[TBL] [Abstract][Full Text] [Related]
18. Static
Song S; Wang L; Yang H; Shan Y; Cheng Y; Xu L; Dong C; Zhao G; Lu J
Eur Radiol; 2021 Jun; 31(6):4087-4096. PubMed ID: 33211141
[TBL] [Abstract][Full Text] [Related]
19. Targeting CD146 with a 64Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas.
Yang Y; Hernandez R; Rao J; Yin L; Qu Y; Wu J; England CG; Graves SA; Lewis CM; Wang P; Meyerand ME; Nickles RJ; Bian XW; Cai W
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6525-34. PubMed ID: 26553993
[TBL] [Abstract][Full Text] [Related]
20. TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative
Unterrainer M; Fleischmann DF; Vettermann F; Ruf V; Kaiser L; Nelwan D; Lindner S; Brendel M; Wenter V; Stöcklein S; Herms J; Milenkovic VM; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1368-1380. PubMed ID: 31486876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
